Congenital adrenal hyperplasia
ORPHA:418Clinical groupAutosomal recessive
Эпидемиология19
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-5 / 10 000 | 13.35 | Europe | Value and class |
| Point prevalence | 1-9 / 100 000 | 10 | Europe | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.7 | Europe | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 8.6 | France | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.65 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 12.8 | Germany | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 10.2 | Sweden | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.6 | United Kingdom | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 7.65 | Netherlands | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 4 | Belgium | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 9.3 | Switzerland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.35 | Japan | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.9 | New Zealand | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.3 | Cuba | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.7 | Taiwan, Province of China | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 38.8 | India | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 4.8 | United States | Value and class |
| Point prevalence | 1-9 / 100 000 | 1.36 | China | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 7.98 | Czech Republic | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)